Cvs Health (CVS) Receivables (2009 - 2026)

Cvs Health has reported Receivables for 18 years, with the latest figure at $47.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 4.75% year-over-year to $47.7 billion; the trailing twelve-month figure through Mar 2026 stood at $47.7 billion (down 4.75% YoY), and the FY2025 full-year result was $50.3 billion, up 8.61% from the prior year.
• Receivables for Q1 2026 stood at $47.7 billion, down from $50.3 billion in the prior quarter.
• The five-year high for Receivables was $55.1 billion in Q3 2025, with the low at $10.4 billion in Q3 2022.
• Historically, Receivables has averaged $34.3 billion across 5 years, with a median of $42.2 billion in 2024.
• Annual changes were most pronounced in 2022 — Receivables slumped 61.28% — and 2023, when it jumped 304.28%.
• Cvs Health's Receivables stood at $11.7 billion in 2022, then jumped by 304.28% to $47.1 billion in 2023, then declined by 1.67% to $46.4 billion in 2024, then grew by 8.61% to $50.3 billion in 2025, then retreated by 5.26% to $47.7 billion in 2026.
• The last three Receivables figures came in at $47.7 billion (Q1 2026), $50.3 billion (Q4 2025), and $55.1 billion (Q3 2025), per Business Quant data.